Following the return of the holiday menu at Starbucks, the merriment continues with the company's annual reusable red cup ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.